Start Date: 2025-01-11
End Date: 2025-01-17

Top Headlines

Main Stories

Bilateral Agreement to Improve Access to Drugs for Rare Diseases in New Brunswick

The Government of Canada and New Brunswick have signed a bilateral agreement, with an investment exceeding $32 million, to improve access to drugs for rare diseases. This agreement aims to provide funding for new and existing drugs, and support early diagnosis and screening. The agreement includes drugs such as Poteligeo, Oxlumo, Epkinly, and Welireg under the National Strategy for Drugs for Rare Diseases. This initiative could significantly improve the affordability and accessibility of treatments for rare diseases in New Brunswick.

Sources: ['Announcements: www.canada.ca']